XML 30 R17.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SHAREHOLDERS' EQUITY
 9 Months Ended
Jun. 30, 2024
Equity [Abstract]  
SHAREHOLDERS' EQUITY SHAREHOLDERS' EQUITY
Share Repurchases
The following summarizes the activity of common stock repurchases for the three and nine month periods ended June 30, 2024 and July 2, 2023.
June 30, 2024July 2, 2023
Three Month Periods Ended
(in millions except per share data)
Number of
Shares
Repurchased
Average
Price
Per Share
Amount
Number of
Shares
Repurchased		Average
Price
Per Share		Amount
Open Market Purchases1.1 $86.22 $92.2 — $— $— 
Private Purchases0.5 93.74 50.0 — — — 
ASR— — — 5.3 74.86 400.0 
Total Purchases1.6 $88.72 $142.2 5.3 $74.86 $400.0 
June 30, 2024July 2, 2023
Nine Month Periods Ended (in millions except per share data)
Number of
Shares
Repurchased		Average
Price
Per Share		AmountNumber of
Shares
Repurchased		Average
Price
Per Share		Amount
Open Market Purchases5.6 $77.48 $432.7 — $— $— 
Private Purchases0.5 93.74 50.0 — — — 
ASR1.3 65.84 83.2 5.3 74.86 400.0 
Total Purchases7.4 $76.66 $565.9 5.3 $74.86 $400.0 
During the nine month period ended June 30, 2024, the Company entered into a $200.0 million rule 10b5-1 repurchase plan to facilitate daily market share repurchases through November 15, 2024, until the cap is reached or until the plan is terminated. On May 20, 2024 this plan was terminated with a total of 1.9 million shares repurchased for $156.0 million.
On May 20, 2024, the Company announced a new $500 million common stock repurchase program authorized by its Board of Directors, replacing the Company's previously approved share repurchase program of $1.0 billion. As part of the approved stock repurchase program, the Company purchased $50.0 million of Common Stock concurrent with the pricing of the offering of the Exchangeable Notes in privately negotiated transactions effected through one of the initial purchasers and/or its affiliates, at market price. Purchases under the program may be made in the open market or in privately negotiated transactions from time to time at management’s discretion. The repurchase program may be suspended or discontinued at any time.

On June 20, 2023, the Company entered into an accelerated share repurchase agreement (the “ASR Agreement”) with a third-party financial institution to repurchase an aggregate of $500.0 million of the Company’s common stock, par value $0.01 per share. The Company funded the share repurchases under the ASR Agreement with cash on-hand following the closing of the sale of the Company’s HHI segment. Pursuant to the agreement, the Company paid $500.0 million to the financial institution at inception of the agreement and took delivery of 5.3 million shares, which represented 80% of the total shares the company expected to receive based on the market price at the time of the initial delivery. The transaction was accounted for as an equity transaction. The fair value of the initial shares received of $400.0 million were recorded as a treasury stock transaction, with the remainder of $100.0 million recorded as a reduction to additional paid-in capital. Upon initial receipt of the shares, there was an immediate reduction in the weighted average common shares calculation for basic and diluted earnings per share. On November 21, 2023, the Company closed and settled the ASR resulting in an additional delivery of 1.3 million shares during the nine month period ended June 30, 2024, with a fair value of $83.2 million. The total number of shares repurchased under the ASR program was 6.6 million at an average cost per share of $75.67, based on the volume-weighted average share price of the Company’s common stock during the calculation period of the ASR program, less the applicable contractual discount.